Ultrasound- Guided Continuous Retro Laminar Block Versus Continuous Erector Spinae Plane Block in Multiple Rib Fractures
Retrolaminar Block, Erector Spinae Plane Block, Spirometry
About this trial
This is an interventional treatment trial for Retrolaminar Block
Eligibility Criteria
Inclusion Criteria: Age from 18 to 65 years old. Both sexes. Patients with unilateral multiple traumatic rib fractures (≥ 3 ribs). Exclusion Criteria: 1st ken refusal. Patients with any contraindication for regional block as: Bleeding disorders. Infection at the injection site. Patients with hemodynamic instability. Patients with known hypersensitivity to the study drugs Unconscious patients Patients with significant trauma outside the chest wall e.g., acute spine or pelvic fracture, severe traumatic brain or spinal cord injury, or abdominal visceral injuries Patients with significant lung contusions, pneumothorax, flail chest Chronic opioid users. Uncooperative patients and patients with psychiatric illness
Sites / Locations
- Tanta UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Group I (Retrolaminar block group)
Group II (Erector spinae plane block group)
Patients received ultrasound guided Retrolaminar block bolus dose of 20 ml 0.25% bupivacaine then continuous infusion at a rate of 0.1 mL/kg/hr. for 4 days
Patients received ultrasound guided Erector spinae plane block bolus dose of 20 ml 0.25% bupivacaine then continuous infusion at a rate of 0.1 mL/kg/hr. for 4 days